MedTrace Logo

A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain

NCT01190722 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-12-02

No results posted yet for this study

Summary

The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).

Conditions

  • Hallux Valgus
  • Postoperative Pain

Interventions

DRUG

etoricoxib

120 mg once daily for the 1st 6 postoperative days

DRUG

Diclofenac

50 mg oral 3 times daily the 1st 6 postoperative days

Sponsors & Collaborators

Principal Investigators

  • Jan Jakobsson, Professor · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-10
Primary Completion
2010-12-11
Completion
2010-12-12

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01190722 on ClinicalTrials.gov